Nelson Van Denburg & Campbell Wealth Management Group LLC Grows Holdings in UnitedHealth Group Inc (NYSE:UNH)

Nelson Van Denburg & Campbell Wealth Management Group LLC raised its position in UnitedHealth Group Inc (NYSE:UNH) by 12.2% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,987 shares of the healthcare conglomerate’s stock after buying an additional 1,409 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC’s holdings in UnitedHealth Group were worth $3,169,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Thoroughbred Financial Services LLC increased its holdings in UnitedHealth Group by 25,321.4% in the second quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock valued at $192,287,000 after buying an additional 1,915,308 shares in the last quarter. Sanders Capital LLC increased its stake in shares of UnitedHealth Group by 50.2% during the second quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock worth $1,255,689,000 after purchasing an additional 1,546,140 shares in the last quarter. Viking Global Investors LP increased its stake in shares of UnitedHealth Group by 28.6% during the second quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock worth $1,174,221,000 after purchasing an additional 1,071,149 shares in the last quarter. Janus Henderson Group PLC increased its stake in shares of UnitedHealth Group by 16.7% during the second quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock worth $1,573,438,000 after purchasing an additional 922,290 shares in the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of UnitedHealth Group by 63.3% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,705,888 shares of the healthcare conglomerate’s stock worth $416,254,000 after purchasing an additional 661,064 shares in the last quarter. 85.66% of the stock is owned by institutional investors.

UNH traded up $1.14 on Friday, reaching $233.99. 74,937 shares of the company’s stock were exchanged, compared to its average volume of 3,729,569. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. The stock has a market cap of $220.35 billion, a PE ratio of 18.16, a P/E/G ratio of 1.24 and a beta of 0.62. The stock’s fifty day moving average price is $238.28 and its 200-day moving average price is $242.80. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94.



UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the consensus estimate of $3.46 by $0.14. The company had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. UnitedHealth Group’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the business posted $3.14 EPS. As a group, research analysts predict that UnitedHealth Group Inc will post 14.84 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $1.08 dividend. The ex-dividend date of this dividend is Friday, September 13th. This represents a $4.32 annualized dividend and a yield of 1.85%. UnitedHealth Group’s payout ratio is 33.54%.

In other news, Director William C. Ballard, Jr. sold 12,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares in the company, valued at approximately $15,652,800.79. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $231.50, for a total transaction of $463,000.00. Following the completion of the transaction, the director now owns 187,979 shares in the company, valued at $43,517,138.50. The disclosure for this sale can be found here. Insiders sold a total of 21,500 shares of company stock worth $5,340,620 over the last quarter. 0.87% of the stock is currently owned by company insiders.

A number of research firms have recently commented on UNH. Credit Suisse Group set a $293.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Thursday, August 29th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $285.00 to $298.00 and gave the stock an “overweight” rating in a research note on Friday, July 12th. Royal Bank of Canada set a $311.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. ValuEngine cut shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, September 5th. Finally, Cantor Fitzgerald set a $310.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seventeen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $291.61.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Which market index is the best?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.